Volume 23, Issue 3, Pages (April 2018)

Slides:



Advertisements
Similar presentations
Tzachi Hagai, Ariel Azia, M. Madan Babu, Raul Andino  Cell Reports 
Advertisements

Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes by Diana Y. Chen, Arumugam Balamurugan,
Volume 37, Issue 3, Pages (September 2012)
Volume 156, Issue 4, Pages (February 2014)
Heather L. Dean, Maureen A. Hagan, Bijan Pesaran  Neuron 
Volume 24, Issue 5, Pages (May 2016)
Volume 16, Issue 5, Pages (August 2016)
Volume 14, Issue 5, Pages (November 2013)
Volume 165, Issue 7, Pages (June 2016)
Volume 23, Issue 4, Pages (April 2015)
Volume 37, Issue 5, Pages (March 2010)
Volume 42, Issue 2, Pages (February 2015)
Heather L. Dean, Maureen A. Hagan, Bijan Pesaran  Neuron 
Volume 23, Issue 11, Pages (June 2018)
Volume 18, Issue 12, Pages (December 2010)
Volume 20, Issue 7, Pages (August 2017)
Alice C.L. Len, Shimona Starling, Maitreyi Shivkumar, Clare Jolly 
Volume 5, Issue 5, Pages (December 2013)
HIV-1 Vpu Mediates HLA-C Downregulation
Volume 21, Issue 1, Pages (October 2017)
Volume 3, Issue 4, Pages (April 2013)
Volume 6, Issue 4, Pages (October 2009)
Volume 16, Issue 9, Pages (August 2016)
Volume 48, Issue 2, Pages e5 (February 2018)
Volume 22, Issue 3, Pages e5 (September 2017)
Volume 18, Issue 5, Pages (January 2017)
Mapping Global Histone Acetylation Patterns to Gene Expression
Volume 43, Issue 6, Pages (December 2015)
Volume 22, Issue 3, Pages (March 2015)
Volume 24, Issue 11, Pages e3 (September 2018)
Volume 23, Issue 2, Pages (April 2018)
Volume 1, Issue 2, Pages (April 2007)
Volume 12, Issue 12, Pages (September 2015)
Volume 21, Issue 6, Pages (June 2013)
Alexander Falkenhagen, Sadhna Joshi  Molecular Therapy - Nucleic Acids 
Adam S. Dingens, Hugh K. Haddox, Julie Overbaugh, Jesse D. Bloom 
Volume 14, Issue 5, Pages (November 2013)
Volume 9, Issue 5, Pages (November 2017)
Volume 21, Issue 10, Pages (December 2017)
Xiaomo Chen, Marc Zirnsak, Tirin Moore  Cell Reports 
Volume 25, Issue 9, Pages e4 (November 2018)
Zika Virus Infects Human Placental Macrophages
Volume 16, Issue 6, Pages (December 2014)
Volume 16, Issue 5, Pages (August 2016)
Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus
Tzachi Hagai, Ariel Azia, M. Madan Babu, Raul Andino  Cell Reports 
Volume 15, Issue 3, Pages (April 2016)
Volume 25, Issue 5, Pages (October 2018)
Volume 8, Issue 4, Pages (October 2010)
Volume 11, Issue 9, Pages (June 2015)
Volume 19, Issue 2, Pages (April 2017)
Structure of the Kinesin13-Microtubule Ring Complex
Volume 4, Issue 3, Pages (September 2008)
Volume 2, Issue 7, Pages (July 1994)
Volume 8, Issue 4, Pages (April 1998)
Volume 24, Issue 7, Pages e5 (August 2018)
Volume 20, Issue 5, Pages (August 2017)
Volume 24, Issue 7, Pages (August 2018)
Volume 49, Issue 2, Pages e8 (August 2018)
HIV Broadly Neutralizing Antibodies: Taking Good Care Of The 98%
Volume 25, Issue 6, Pages e5 (June 2019)
Volume 17, Issue 6, Pages (November 2016)
An Mll-Dependent Hox Program Drives Hematopoietic Progenitor Expansion
Cure of HIV infection: Is the long wait over?
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
Atsushi Yamanaka, Eiji Konishi
Volume 49, Issue 6, Pages e8 (December 2018)
Volume 18, Issue 5, Pages (January 2017)
Volume 17, Issue 5, Pages (October 2016)
Volume 24, Issue 4, Pages e3 (October 2018)
Presentation transcript:

Volume 23, Issue 3, Pages 682-691 (April 2018) Superinfection Drives HIV Neutralizing Antibody Responses from Several B Cell Lineages that Contribute to a Polyclonal Repertoire  Katherine L. Williams, Bingjie Wang, Dana Arenz, James A. Williams, Adam S. Dingens, Valerie Cortez, Cassandra A. Simonich, Stephanie Rainwater, Dara A. Lehman, Kelly K. Lee, Julie Overbaugh  Cell Reports  Volume 23, Issue 3, Pages 682-691 (April 2018) DOI: 10.1016/j.celrep.2018.03.082 Copyright © 2018 The Authors Terms and Conditions

Cell Reports 2018 23, 682-691DOI: (10.1016/j.celrep.2018.03.082) Copyright © 2018 The Authors Terms and Conditions

Figure 1 Neutralization of Select Virus Panels by QA013 Isolated mAbs and Plasma (A) Virus panel only including viruses neutralized by QA013 2,282 dpi plasma. (B) Global reference panel (deCamp et al., 2014). IC50 values are averaged from 2–3 experiments performed in duplicate. Values are color coded so that the shade of blue correlates with IC50 potency. If 50% neutralization was not achieved, the highest mAb concentration or lowest plasma dilution tested is recorded and the cell is shaded gray. Cell Reports 2018 23, 682-691DOI: (10.1016/j.celrep.2018.03.082) Copyright © 2018 The Authors Terms and Conditions

Figure 2 QA013.2 Epitope Mapping (A) mAbs tested are indicated above each column. Virus pairs are indicated to the left, and the fold increase or decrease in relative IC50 values is calculated by dividing the IC50 value measured against the virus without the N332 residue by the IC50 value measured against the virus with the residue. IC50 values are the average of at least two experiments performed in duplicate. See Figure S1. (B) Negative stain electron microscopy reconstruction of QA013.2 Fab in complex with BG505.W6M.C2 SOSIP trimers indicates that the N332 supersite at the base of V3 is targeted by this nAb. See Figure S2. Cell Reports 2018 23, 682-691DOI: (10.1016/j.celrep.2018.03.082) Copyright © 2018 The Authors Terms and Conditions

Figure 3 Neutralization of the QA013 Autologous Virus Panel The viruses tested are on the left of each row, and the antibodies are indicated at the top of each column. IC50 values indicate the average of two or three independent experiments and are color coded according to potency. See also Figures S3 and S4. Cell Reports 2018 23, 682-691DOI: (10.1016/j.celrep.2018.03.082) Copyright © 2018 The Authors Terms and Conditions

Figure 4 nAb Binding to Cell-Surface-Expressed QA013 Autologous Envs (A) Binding data based on flow cytometry. Data indicate the average percent binding from duplicate measurements from two independent experiments. Error bars represent the SD. The antibodies tested are indicated on the x axis, with VRC01 and C11 serving as staining controls. The Envs tested are coded as indicated to the right of the figure; specific characteristics, including the virus clade, whether the virus is considered to be of the transmitted/founder (T/F) strain, and neutralization sensitive (sens), are also indicated. See also Figure S4. (B) Percent binding compared to neutralization IC50 for each virus/mAb pair. Percent binding was calculated relative to control mAb VRC01 and expressed as a percentage. Darker shades of pink indicate a larger percentage of positive cells compared to VRC01, while darker shades of blue indicate more potent neutralizing activity. Cell Reports 2018 23, 682-691DOI: (10.1016/j.celrep.2018.03.082) Copyright © 2018 The Authors Terms and Conditions

Figure 5 Neutralization of Initial and Superinfecting Primary Virus Isolates and Frequency of N332 Codon over Time (A–D) The plasma (A) or nAb (B–D) tested is indicated at the top of the graph, and the key to the virus tested is provided to the right. Data represent the average of two independent experiments performed in duplicate. Error bars represent the SD. (E) Summary of the longitudinal frequency of initial versus superinfecting virus, parsed by the presence of PNG motifs at sites 332 and 334. The initial infecting clade D virus is designated in shades of blue, while the superinfecting clade A virus is shown in shades of red. A black line separates the aggregate frequency of clade D versus clade A viruses over time. Days 0–70 post-infection are shown in blue stripes to indicate that the virus is presumed to be clade D based on viral sequences at day 70, the first time point sequenced. The shade colors indicate differences in the presence of a glycan at N332 or N334, as shown to the right, where only the virus in darker red encodes the N332 glycan. Data are the average of technical Illumina sequencing replicates (R = 0.997). Cell Reports 2018 23, 682-691DOI: (10.1016/j.celrep.2018.03.082) Copyright © 2018 The Authors Terms and Conditions